Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Day 100 Peripheral Blood Absolute Lymphocyte/Monocyte Ratio and Survival in Classical Hodgkin's Lymphoma Postautologous Peripheral Blood Hematopoietic Stem Cell Transplantation
Porrata, Luis F. , Inwards, David J. , Ansell, Stephen M. , Micallef, Ivana N. , Johnston, Patrick B. , Hogan, William J. , Markovic, Svetomir N.

Bone Marrow Research | April 28, 2013 | Volume: 2013 | Issue: No issue available | Pages: 1-8

10.1155/2013/658371 | PMID 23710362 Get It

Day 100 prognostic factors of postautologous peripheral blood hematopoietic stem cell transplantation (APBHSCT) to predict clinical outcome in classical Hodgkin lymphoma (cHL) patients have not been evaluated. Thus, we studied if the day 100 peripheral blood absolute lymphocyte/monocyte ratio (Day 100 ALC/AMC) affects clinical outcomes by landmark analysis from day 100 post-APBHSCT. Only cHL patients achieving a complete remission at day 100 post-APBHSCT were studied. From 2000 to 2010, 131 cHL consecutive patients qualified for the study. The median followup from day 100 was 4.1 years (range: 0.2–12.3 years). Patients with a Day 100 ALC/AMC ≥ 1.3 experienced superior overall survival (OS) and progression-free survival (PFS) compared with Day 100 ALC/AMC < 1.3 (from day 100: OS, median not reached versus 2.8 years; 5 years OS rates of 93% (95% CI, 83%–97%) versus 35% (95% CI, 19%–51%), resp.,P<0.0001; from day 100: PFS, median not reached versus 1.2 years; 5 years PFS rates of 79% (95% CI, 69%–86%) versus 27% (95% CI, 14%–45%), resp.,P<0.0001). Day ALC/AMC ratio was an independent predictor for OS and PFS. Thus, Day 100 ALC/AMC ratio is a simple biomarker that can help to assess clinical outcomes from day 100 post-APBHSCT in cHL patients.
Clinical implications of the Third Universal Definition of Myocardial Infarction
Thygesen, Kristian , Alpert, Joseph S., Jaffe, Allan S. , White, Harvey Douglas , Jaffe, Allan S.

Heart | April 27, 2013 | Volume: 100 | Issue: 5 | Pages: 424-432

10.1136/heartjnl-2012-302976 | PMID 23624485 Get It

TNFRSF1A polymorphisms and MS
Weinshenker, Brian, Tienari, Pentti J. , Weinshenker, Brian G. , Weinshenker, Brian G

Neurology | April 27, 2013 | Volume: 80 | Issue: 22 | Pages: 2002-2003

10.1212/wnl.0b013e318294b4ab | PMID 23624561 Get It

Aortic pulse wave velocity and reflecting distance estimation from peripheral waveforms in humans: detection of age- and exercise training-related differences
Casey, Darren P. , Fiedorowicz, Jess G. , Curry, Timothy B. , Barnes, Jill N. , Wilson, DeMaris R., Pierce, Gary L. , Seals, Douglas R. , Stauss, Harald Martin , Barnes, J N , Fiedorowicz, Jess G

American Journal of Physiology-Heart and Circulatory Physiology | April 27, 2013 | Volume: 305 | Issue: 1 | Pages: H135-H142

10.1152/ajpheart.00916.2012 | PMID 23624628 Get It

We hypothesized that demographic/anthropometric parameters can be used to estimate effective reflecting distance (EfRD), required to derive aortic pulse wave velocity (APWV), a prognostic marker of cardiovascular risk, from peripheral waveforms and that such estimates can discriminate differences in APWV and EfRD with aging and habitual endurance exercise in healthy adults. Ascending aortic pressure waveforms were derived from peripheral waveforms (brachial artery pressure, n = 25; and finger volume pulse, n = 15) via a transfer function and then used to determine the time delay between forward- and backward-traveling waves (Δ tf-b). True EfRDs were computed as directly measured carotid-femoral pulse wave velocity (CFPWV) × ½Δ tf-b and then used in regression analysis to establish an equation for EfRD based on demographic/anthropometric data (EfRD = 0.173·age + 0.661·BMI + 34.548 cm, where BMI is body mass index). We found good agreement between true and estimated APWV (Pearson's R2 = 0.43; intraclass correlation = 0.64; both P < 0.05) and EfRD ( R2 = 0.24; intraclass correlation = 0.40; both P < 0.05). In young sedentary (22 ± 2 years, n = 6), older sedentary (62 ± 1 years, n = 24), and older endurance-trained (61 ± 2 years, n = 14) subjects, EfRD (from demographic/anthropometric parameters), APWV, and ½Δ tf-b (from brachial artery pressure waveforms) were 52.0 ± 0.5, 61.8 ± 0.4, and 60.6 ± 0.5 cm; 6.4 ± 0.3, 9.6 ± 0.2, and 8.1 ± 0.2 m/s; and 82 ± 3, 65 ± 1 and 76 ± 2 ms (all P < 0.05), respectively. Our results demonstrate that APWV derived from peripheral waveforms using age and BMI to estimate EfRD correlates with CFPWV in healthy adults. This method can reliably detect the distal shift of the reflecting site with age and the increase in APWV with sedentary aging that is attenuated with habitual endurance exercise.
Physical Health Status Measures Predict All-Cause Mortality in Patients With Heart Failure
Chamberlain, Alanna M. , McNallan, Sheila M, Spertus, John A. , Redfield, Margaret M. , Moser, Debra K. , Kane, Robert L , Weston, Susan A., Roger, Véronique L. , Dunlay, Shannon M. , Chamberlain, Alanna M , Spertus, John A

Circulation: Heart Failure | April 26, 2013 | Volume: 6 | Issue: 4 | Pages: 669-675

10.1161/circheartfailure.112.000291 | PMID 23625946 Get It

Background— Physical health status measures have been shown to predict death in heart failure (HF); however, few studies found significant associations after adjustment for confounders, and most were not representative of all HF patients. Methods and Results— HF patients from southeastern MN were prospectively enrolled between 10/2007 and 12/2010, completed a 12-item Short Form Health Survey (SF-12) and a 6-minute walk, and were followed through 2011 for death from any cause. Scores ≤25 on the SF-12 physical component indicated low self-reported physical functioning, and the first question of the SF-12 measured self-rated general health. Low functional exercise capacity was defined as ≤300 m walked during a 6-minute walk. Over a mean follow-up of 2.3 years, 86 deaths occurred among the 352 participants. A 1.6-fold (95% confidence interval, 1.0–2.7) and 1.8-fold (95% confidence interval, 1.1–2.9) increased risk of death was observed among patients with low self-reported physical functioning and low functional exercise capacity, respectively. Poor self-rated general health corresponded to a 2.7-fold (95% confidence interval, 1.5–4.9) increased risk of death compared with good to excellent general health. All measures equally discriminated between who would die and who would survive (C-statistics: 0.729, 0.750, and 0.740 for self-reported physical functioning, self-rated general health, and functional exercise capacity, respectively). Conclusions— Three physical health status measures, captured by the SF-12 and a 6-minute walk, equally predict death among community HF patients. Therefore, the first question of the SF-12, which is the least burdensome to administer, may be sufficient to identify HF patients at greatest risk of death.
Macro Creatine Kinase Type 1
Bodensteiner, John B.

Journal of Child Neurology | April 26, 2013 | Volume: 29 | Issue: 7 | Pages: 973-976

10.1177/0883073813484805 | PMID 23625087 Get It

Macro creatine kinase type 1 is a complex formed by the creatine kinase isoenzyme BB and monoclonal IgG and occurs in about 1% of patients studied. First identified as a cause of spurious elevation of the total serum creatine kinase in patients suspected of myocardial infarction, the test has been largely replaced by the measurement of troponin levels. We present a child with delayed milestones and persistently elevated total serum creatine kinase measurements (∼1000-4000 IU) normal electromyogram and brisk myotatic reflexes. Creatine kinase isoenzymes and brain imaging showed the presence of macro creatine kinase type 1 and extensive signal abnormality of the cerebral white matter. Macro creatine kinase type 1 has been associated with several conditions though it has not been described in association with leukoencephalopathy or in patients this young. Macro creatine kinase type 1 can be a cause of elevated total creatine kinase in patients without primary muscle disease. The significance of the relationship of the macro creatine kinase to the leukoencephalopathy in this patient is unknown.
Electromyogram-triggered inspiratory event detection algorithm
Dow, Douglas E. , Petrilli, Anita M., Mantilla, Carlos B. , Zhan, Wen‐Zhi, Sieck, Gary C. , Sieck, Gary , Mantilla, Carlos B

The 6th International Conference on Soft Computing and Intelligent Systems, and The 13th International Symposium on Advanced Int | April 26, 2013 | Volume: No volume available | Issue: No issue available | Pages: 789-794

10.1109/scis-isis.2012.6505353 Get It

Quality Guidelines for Next-Generation Sequencing
Baudhuin, Linnea M.

Clinical Chemistry | April 26, 2013 | Volume: 59 | Issue: 5 | Pages: 858-859

10.1373/clinchem.2013.203091 | PMID 23757769 Get It

Commentary
Pruthi, Rajiv K.

Clinical Chemistry | April 26, 2013 | Volume: 59 | Issue: 5 | Pages: 750-751

10.1373/clinchem.2012.195255 | PMID 23624896 Get It

Risk Factors for Excessive Anticoagulation Among Hospitalized Adults Receiving Warfarin Therapy Using a Pharmacist‐Managed Dosing Protocol
Berg, Tamara M., O’Meara, John G. , Ou, Narith N., Daniels, Paul R. , Moriarty, James P. , Bergstrahl, Eric J., Dierkhising, Ross , Manning, Dennis M.

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | April 26, 2013 | Volume: 33 | Issue: 11 | Pages: 1165-1174

10.1002/phar.1280 | PMID 23625787 Get It

Study ObjectiveTo identify specific risk factors for excessive anticoagulation, defined as an international normalized ratio (INR) higher than 5, in hospitalized adults receiving warfarin therapy using a pharmacist‐managed dosing protocol.DesignRetrospective nested case‐control study.SettingLarge academic tertiary care medical center.PatientsHospitalized nonsurgical patients 18 years or older who received at least one dose of warfarin according to the pharmacist‐managed protocol from January 1, 2009, to January 31, 2012, were included. Patients who experienced an INR higher than 5 were designated as case patients; those who received warfarin for at least as many days as the case patients but who did not experience an INR more than 5 were deemed control patients. Controls were matched to cases in a 2:1 ratio by age, sex, INR goal, and type of warfarin therapy (new start or continuation).Measurements and Main ResultsA total of 87 case patients were matched to 174 controls. Ten different hypothesized risk factors were examined. Two variables, severity of illness score (odds ratio [OR] 4.89, p<0.001) and poor nutritional status (OR 4.27, p<0.001), demonstrated strong independent associations with risk of excessive anticoagulation. Administration of interacting drugs that highly potentiate warfarin's effect (OR 2.26, p=0.011) and concurrent diarrheal illness (OR 4.75, p<0.001) also displayed a statistically significant risk for excessive anticoagulation.ConclusionEven in a highly standardized system for warfarin dosing by a pharmacist‐managed protocol, higher disease severity and poor nutritional status placed hospitalized patients at greater risk of experiencing excessive anticoagulation. In addition, administration of interacting drugs that highly potentiate warfarin's effect or the occurrence of diarrheal illness may predict increased risk.